Institutional Fund
Primecap Management Co/Ca/
Pasadena, CACIK 7632125 filings on record
Portfolio Value
$127.01B
Q1 2026
Holdings
320
Reported positions
New Buys
9
Opened this quarter
QoQ Change
-3.9%
from $132.11B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Eli Lilly & Co6.7%
- Micron Technology Inc5.8%
- Alphabet Inc3.4%
- Astrazeneca PLC2.8%
- Kla Corp2.8%
- Intel Corp2.6%
- Other75.8%
Portfolio Holdings
320 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | 9.22M | $8.48B | 6.7% | −42.4K | Reduced |
| 2 | Micron Technology Inc | 21.87M | $7.39B | 5.8% | −2.92M | Reduced |
| 3 | Alphabet Inc | 14.99M | $4.31B | 3.4% | −140.8K | Reduced |
| 4 | Astrazeneca PLC | 18.21M | $3.59B | 2.8% | +18.21M | New |
| 5 | Kla Corp | 2.44M | $3.59B | 2.8% | −438.3K | Reduced |
| 6 | Intel Corp | 75.76M | $3.34B | 2.6% | −370.3K | Reduced |
| 7 | Amgen Inc | 8.87M | $3.12B | 2.5% | −30.9K | Reduced |
| 8 | Nvidia Corporation | 17.19M | $3.00B | 2.4% | −39.3K | Reduced |
| 9 | Fedex Corp | 8.30M | $2.96B | 2.3% | −209.7K | Reduced |
| 10 | Biogen Inc | 14.76M | $2.71B | 2.1% | −390 | Reduced |
310 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio